Sun, Dec 21, 2014, 6:08 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • chevymalibu1966 chevymalibu1966 Dec 10, 2012 2:31 PM Flag

    news coming?

    not sure if you fellas know but I posted friday saying volume was higher. I didn't know why till this weekend. DB upgraded or reiterated it's "BUY" rating and said 56 target. Gave more details but this is the gist. If anyone wants more details (about 2-3 sentences), I'll post if asked and when I get time. THX

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • If one looks to the last financial report there are triggers coming too.

      "-Third quarter 2012 total revenues of $336 million, including third quarter 2012 net product revenues of approximately $254 million for INCIVEK in hepatitis C and $49 million for KALYDECO in cystic fibrosis-

      -Cystic Fibrosis: Three ongoing Phase 3 label expansion studies for ivacaftor monotherapy; pivotal program for VX-809 and ivacaftor combination expected to begin in early 2013-

      -Hepatitis C: Planned start of first all-oral Phase 2 study of VX-135 by the end of 2012; agreements with GlaxoSmithKline and Janssen Pharmaceuticals announced today provide opportunity to study VX-135 in additional all-oral regimens in Phase 2 studies-"

      As to triggers, Kalydeco was recently approved in Canada so more countries should be coming online soon too and sales will increase.

      Sentiment: Strong Buy

 
VRTX
118.90+1.16(+0.99%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.